MENU
+Compare
HOOK
Stock ticker: NASDAQ
AS OF
Apr 3 closing price
Price
$0.85
Change
-$0.07 (-7.61%)
Capitalization
10.26M

HOOK HOOKIPA Pharma Inc. Forecast, Technical & Fundamental Analysis

HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system... Show more

HOOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for HOOK with price predictions
Apr 03, 2025

HOOK's RSI Oscillator is staying in oversold zone for 3 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HOOK advanced for three days, in of 223 cases, the price rose further within the following month. The odds of a continued upward trend are .

HOOK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on HOOK as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for HOOK turned negative on April 02, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HOOK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for HOOK entered a downward trend on April 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.216) is normal, around the industry mean (13.581). P/E Ratio (0.000) is within average values for comparable stocks, (64.662). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.879). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.262) is also within normal values, averaging (248.206).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. HOOK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HOOK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
HOOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

HOOK is expected to report earnings to fall 195.45% to -10 cents per share on August 08

HOOKIPA Pharma Inc. HOOK Stock Earnings Reports
Q2'24
Est.
$-0.10
Q1'24
Beat
by $0.21
Q4'23
Missed
by $0.03
Q3'23
Beat
by $0.04
Q2'23
Missed
by $0.01
The last earnings report on May 09 showed earnings per share of 10 cents, beating the estimate of -10 cents. With 108.64K shares outstanding, the current market capitalization sits at 10.26M.
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company which develops pharmaceutical products for immunotherapeutics targeting infectious diseases and cancers

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
350 Fifth Avenue, 72nd Floor
Phone
+1 431 890-6360
Employees
179
Web
https://www.hookipapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATLO16.56-0.88
-5.05%
Ames National Corp
XERS4.88-0.27
-5.24%
Xeris Biopharma Holdings
HCC43.91-2.78
-5.95%
Warrior Met Coal
RLMD0.28-0.03
-8.97%
Relmada Therapeutics
SYF46.56-8.49
-15.42%
Synchrony Financial

HOOK and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HOOK has been loosely correlated with QURE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if HOOK jumps, then QURE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOOK
1D Price
Change %
HOOK100%
-7.22%
QURE - HOOK
44%
Loosely correlated
-8.19%
MTVA - HOOK
44%
Loosely correlated
-0.65%
VSTM - HOOK
38%
Loosely correlated
-2.23%
GMAB - HOOK
32%
Poorly correlated
+2.23%
PYXS - HOOK
31%
Poorly correlated
-8.28%
More

Groups containing HOOK

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOOK
1D Price
Change %
HOOK100%
-7.22%
HOOK
(1 stocks)
71%
Closely correlated
-7.22%